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Background: The purpose of this study was to evaluate the auditory brain stem response (ABR) 
and acoustic emissions of the inner ear (OAE) in middle-aged type 2 diabetics.
Methods: Fifty type 2 diabetic and nondiabetic patients aged 40–50 years and attending the 
Tabriz Medical University outpatient clinics were recruited for this study during 2009–2010. 
All ABR and OAE procedures were implemented by an audiometrist. The relationship 
between ABR and OAE findings and demographic, laboratory, and clinical characteristics 
was investigated.
Results: Fifty patients (34 female and 16 male) of average age 45.7 ± 3.0 years were entered 
into the study. In the type 2 diabetic group, disordered ABR was found in at least one ear in 8% 
of cases and disordered OAE was recorded in at least one ear in 16% of cases, with no significant 
difference between the diabetic and nondiabetic groups. Mean age, duration of diabetes, serum 
HbA1c levels, and prevalence of female gender were higher in the diabetic group.
Conclusion: According to our findings, the prevalence of ABR and OAE is not significantly 
different between type 2 diabetics and nondiabetics.
Keywords: sensorineural hearing loss, diabetes, auditory brain stem response, otoacoustic 
emission
Introduction
Technological advances, the increasing prevalence of diabetes, and significance of 
hearing in people’s lives have contributed to a rising number of studies of disordered 
auditory function in diabetes sufferers. Destruction of the inner hair cells of the cochlea 
has been reported to be the cause of hearing loss in these people.1,2 After exploration 
of the cochlea structure in diabetics, Fukushima et al proposed cochlear angiopathy 
and degeneration of the outer hair cells as likely causes of deafness in this group.3 
Otoacoustic emission (OAE) testing of the inner ear can be helpful for diagnosis of 
cochlear-related hearing impairment. If the cochlea is damaged, OAE from the cochlea 
will be disturbed, whereas if the retrocochlear neural pathway is damaged, the OAE 
will be normal but the auditory brain stem response (ABR) will be abnormal.4,5
Simoncelli et al demonstrated that the intensity and amplitude of recorded waves 
for OAE in diabetics were significantly lower than in a control group, and attributed 
this to a disorder in the hair cells of the cochlear.6 Nowadays, a number of educational 
institutions are equipped with OAE and ABR testing facilities, and given the numerous 
diabetics in our region, the importance of hearing, and lack of research on the subject, 
we evaluated OAE and ABR in a group of type 2 diabetics.International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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Materials and methods
Our study was performed at Tabriz University of   Medical 
Sciences over a period of 12 months from August 2009 to 
  September 2010. The study was approved by the   ethical 
  committee of the Islamic Azad University of Tabriz. 
Fifty type 2 diabetic patients and 50 healthy nondiabetic 
individuals aged 40–50 years were recruited for ABR and 
OAE testing.   Exclusion criteria included congenital   hearing 
loss from childhood, trauma-induced hearing loss, and a 
history of chronic otitis media. A full medical history and 
examination was performed for all patients. The ABR and 
OAE tests were then performed separately by an expert 
audiologist. The standards for ABR (90 dB nHL, 30 impulses, 
click 125 msec half-wave squared) used were: I, 1.97 msec; 
III, 4.2 msec; V , 6.2 msec; interpeak latency: I–III, 2.2 msec; 
III–V , 2 msec; and I–V , 4.2 msec.
Diagnostic decisions were based on measurement of 
V wave latency and its interural latency. Demographic, 
laboratory, and clinical data were sought by a questionnaire 
devised in the Tabriz Medical Science Department. The infor-
mation recorded included family history, past medical history, 
blood pressure, cholesterol levels, fasting blood sugar, HbA1c, 
and serum creatinine levels. The questionnaire had been pre-
tested in a small pilot population and modified as necessary.
statistical analysis
The Mann–Whitney U test was used to compare quantitative data 
and Fisher’s Exact test was used to compare qualitative data. In 
all cases, P # 0.05 was considered to be statistical significant.
Results
Sixteen subjects (32%) were male and 34 were female (68%). 
Mean age was 45.7 ± 3.0 years. Average weight was 80.3 ± 15.8 
(range 50–145) kg. Mean duration of disease in the diabetic 
group was 8.2 ± 5.1 years. At admission, mean fasting blood 
sugar was 171.2 ± 68.3 (83–395) mg/dL, mean HbA1c was 
8.0 ± 1.6 (5.1–12) percent, and mean serum creatinine was 
0.9 ± 0.2 (0.5–1.8) mg/dL. There were complaints of hear-
ing loss in 18 (36%) cases, having noise in the ear in nine 
(18%) cases, and vertigo in 21 (42%) cases. Thirty-eight 
(76%) diabetic patients had high cholesterol, 20 (40%) had 
hypertension, three (6%) had ischemia, and one (2%) had 
anemia. Examination of the ears was normal in all cases. 
Forty (80%) were using metformin, 27 (54%) glibenclamide, 
11 (22%) insulin, two (4%) a glitazone, 30 (60%) aspirin, 25 
(50%), atorvastatin, four (8%) atenolol, and one each (2%) was 
on clonazepam, propranolol, nitrocantin, and fluoxetine.
Abnormal ABR was recorded in the right ear in four (8%) 
cases (one deafness, three 30 dB hearing loss) and in the left 
ear in three (6%) cases (30 dB hearing loss). Three cases 
suffered from bilateral hearing loss of 30 dB on average. The 
most common finding in ABR was increased V wave latency. 
Abnormal OAE was found in both ears in seven (14%) cases, 
in the right ear in eight (16%) cases, and in the left ear in seven 
(14%) cases. Both abnormal ABR and OAE was found in four 
(8%) cases and either abnormal ABR or OAE was found in 
one ear in eight (16%) cases. Comparison of data collected by 
questionnaire based on the presence or absence of abnormal 
ABR in one ear is summarized in Table 1. There was no sta-
tistically significant difference between any of the variables. 
Tables 2–4 summarize the comparison of variables according to 
the presence or absence of abnormal OAE in at least one ear.
Discussion
In diabetics, we found abnormal ABR in at least one ear in 8% 
of cases, abnormal OAE in at least one ear in 16% of cases, 
Table 1 comparison of demographic, clinical, and laboratory characteristics according to existence of disordered ABr and OAe in 
one ear in diabetic patients
Variable Normal ABR and OAE  
(n = 46)*
Abnormal ABR and OAE  
(n = 4)
P
Age (years) (48) 48 ± 2 (46) 46 ± 3 0.256
Gender (male) (35) 16 (0) 0 0.495
Duration of diabetes (years) (7) 8 ± 2 (6) 8 ± 5 0.593
hbA1c (%) (9) 9 ± 2 (8) 8 ± 2 0.928
serum creatinine (mg/dL) (1) 1 ± 0 (1) 1 ± 0 0.928
high cholesterol (76) 35 (75) 3 0.679
high blood pressure (41) 19 (25) 1 0.472
complaint of hearing loss (35) 16 (50) 2 0.456
existing noise in ear (20) 9 (0) 0 0.444
complaint of vertigo (39) 18 (75) 3 0.193
Note: *All values after n values are ranges. 
Abbreviations: ABr, auditory brain stem response; OAe, acoustic emission of inner ear.International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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abnormal ABR or OAE in at least one ear in 16% of cases, and 
an abnormality of both ABR and OAE in at least one ear in 8% 
of cases. Soveid et al compared tonic and verbal audiometry in 
80 diabetics of mean age 49 years with a control group of 78 
healthy nondiabetics. Hearing loss and speech impairment was 
noted more often in the diabetic group than in controls, but the 
difference was not statistically significant,7 and hearing loss 
was reported to be significantly greater in the diabetic group. 
Konrad-Martin et al investigated ABR in 166 diabetics and 138 
healthy controls under the age of 50 years, and reported signifi-
cantly more cases of disordered ABR in the diabetic group.8 
Lisowska et al studied 42 diabetics aged 21–42 years and 33 
healthy controls using ABR and OAE, and reported that latency 
of ABR was significantly greater and that OAE amplitude was 
significantly reduced in the diabetic group.9 They concluded 
that there is a disorder in the central micromechanical cochlear 
and retrocochlear auditory pathways in diabetics. Ottaviani 
et al compared 60 insulin-dependent diabetics of average age 
31 years with 58 controls using OAE. In their study, 28.3% 
had impaired OAE in one ear and 10% had impaired OAE in 
both ears,10 and it was concluded that there is cochleopathy 
in diabetes. Orts Alborch et al investigated 20 diabetics and 
20 healthy controls using OAE. In their study, amplitude was 
significantly lower than in controls, and they hypothesized that 
the cochlear disorder in diabetics arises from altered function 
of the outer hair cells.11
In the present study, we investigated additional variables 
potentially involved in auditory damage in diabetics. We 
found that average age, duration of diabetes, serum HbA1c, 
and preponderance of female gender was higher in diabetics 
with disordered ABR and OAE than in controls. However, 
these differences did not reach statistical significance, 
although the difference in HbA1c level was more marked 
than for the other variables.
The results of the different studies in this field vary widely, 
with some reporting that age, duration of disease, and HbA1c 
Table 2 comparison of demographic, clinical, and laboratory characteristics according to existence of disordered ABr in one ear in 
diabetic patients
Variable Normal ABR and OAE  
(n = 46)*
Abnormal ABR and OAE  
(n = 4)
P
Age (years) (46) 46 ± 3 (48) 48 ± 2 0.256
Gender (male) (35) 16 (0) 0 0.201
Duration of diabetes (years) (6) 8 ± 5 (7) 8 ± 2 0.593
hbA1c (%) (8) 8 ± 2 (9) 9 ± 2 0.307
serum creatinine (mg/dL) (1) 1 ± 0 (1) 1 ± 0 0.928
high cholesterol (76) 35 (75) 3 0.679
high blood pressure (41) 19 (25) 1 0.472
complaint of hearing loss (35) 16 (50) 2 0.456
existing noise in ear (20) 9 (0) 0 0.440
complaint of vertigo (39) 18 (75) 3 0.193
Note: *All values after n values are ranges. 
Abbreviations: ABr, auditory brain stem response; OAe, acoustic emission of inner ear.
Table 3 comparison of demographic, clinical, and laboratory characteristics according to existence of disordered OAe in one ear in 
diabetic group
Variance Normal ABR and OAE  
(n = 46)*
Abnormal ABR and OAE  
(n = 4)
P
Age (years) (46) 46 ± 3 (47) 46 ± 4 0.541
Gender (male) (33) 14 (25) 2 0.495
Duration of diabetes (years) (6) 8 ± 5 (8) 9 ± 3 0.099
hbA1c (%) (7) 8 ± 2 (9) 9 ± 2 0.067
serum creatinine (mg/dL) (1) 1 ± 0 (1) 1 ± 0 0.314
high cholesterol (79) 33 (63) 5 0.287
high blood pressure (43) 18 (25) 2 0.297
complaint of hearing loss (33) 14 (50) 4 0.303
existing noise in ear (17) 7 (25) 2 0.445
complaint of vertigo (38) 16 (63) 5 0.186
Note: *All values after n values are ranges. 
Abbreviations: ABr, auditory brain stem response; OAe, acoustic emission of inner ear.International Journal of General Medicine
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levels are correlated with hearing impairment, and others not 
being able to replicate these observations. We did not include 
patients over 50 years of age because this age group has an 
increased rate of presbyacusia, which is a type of sensorineu-
ral hearing loss. Our results, especially for HbA1c, suggest that 
our diabetic population was well trained in diabetes control, 
had good compliance with medication, attended clinic regu-
larly, and had a disease duration of less than 10 years. This 
could have contributed to the low rate of ocular and renal 
side effects reported on their questionnaires. If our diabetic 
sample size was larger and/or had been selected at random 
from the community, our results may have been different. 
Many of the side effects of diabetes are potentially control-
lable with appropriate instruction and consistent blood sugar 
control. Raising public awareness about diabetes and regular 
follow-up of patients can play a key role in the control of this 
disease and its side effects.
Conclusion
Our study did not detect any significant acoustic emission 
disorder of the inner ear or brain stem in type 2 diabetics. 
However, larger and preferably multicenter studies would be 
needed to confirm our negative findings.
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